Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the management of the Company shall be meeting analysts/investors through Trinity India -2023 Annual Investor Conference hosted by Batlivala & Karani Securities India (‘B&K’) on 1st June, 2023.
The above information is a part of company’s filings submitted to BSE.